Anika Therapeutics Inc (ANIK)
27.59
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
27.74
+0.15
(+0.54%)
After-Hours: 20:00
Anika Therapeutics Revenue (Annual): 166.66M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 166.66M |
| December 31, 2022 | 156.24M |
| December 31, 2021 | 147.79M |
| December 31, 2020 | 130.46M |
| December 31, 2019 | 114.61M |
| December 31, 2018 | 105.56M |
| December 31, 2017 | 113.42M |
| December 31, 2016 | 103.38M |
| December 31, 2015 | 93.00M |
| December 31, 2014 | 105.60M |
| December 31, 2013 | 75.08M |
| December 31, 2012 | 71.36M |
| December 31, 2011 | 64.78M |
| December 31, 2010 | 55.56M |
| December 31, 2009 | 40.14M |
| December 31, 2008 | 35.78M |
| Date | Value |
|---|---|
| December 31, 2007 | 30.83M |
| December 31, 2006 | 26.84M |
| December 31, 2005 | 29.83M |
| December 31, 2004 | 26.46M |
| December 31, 2003 | 15.40M |
| December 31, 2002 | 13.19M |
| December 31, 2001 | 11.31M |
| December 31, 2000 | 16.34M |
| December 31, 1999 | 13.83M |
| December 31, 1998 | 13.27M |
| December 31, 1997 | 12.00M |
| December 31, 1996 | 1.20M |
| August 31, 1996 | 4.60M |
| August 31, 1995 | 3.40M |
| August 31, 1994 | 4.70M |
| August 31, 1993 | 2.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
114.61M
Minimum
2019
166.66M
Maximum
2023
143.15M
Average
147.79M
Median
2021
Revenue (Annual) Benchmarks
| The Cooper Companies Inc | 3.593B |
| Staar Surgical Co | 322.42M |
| OrthoPediatrics Corp | 148.73M |
| NexGel Inc | 4.089M |
| Innovative Eyewear Inc | 1.152M |